Rebounding coronary procedure volumes augmented growth in the total interventional cardiology market in Q1 2007, after severe decline in December 2006.
Waltham, Massachusetts (PRWEB) April 20, 2007 -- Millennium Research Group's (MRG) Marketrack service reveals that the interventional cardiology market value increased 1.5% in Q1 2007 over Q4 2006.
Coronary stents, percutaneous transluminal coronary angioplasty (PTCA) balloons, intravascular ultrasound (IVUS) catheters, thrombectomy devices and atheterectomy devices all grew in market value after a slow December in 2006.
"In December we saw percutaneous coronary intervention (PCI) procedures and revenues on the decline, but it seems that this past quarter has shown an increase," say Bina Mistry, analyst at MRG. "Risks associating drug coated stents with late stent thrombosis slowed down procedure volumes in December. In Q1 2007, however, PCI procedures increased with less hesitation by physicians to perform this treatment option. Moreover, an increase in PTCA balloon, thrombectomy, and atherectomy procedures was also noticed - such procedures can replace stent procedures in patients suffering from coronary artery disease (CAD).
Furthermore, increased screening initiatives through diagnostic angiographies which diagnose CAD in patients has increased in Q1 2007 over Q1 2006. As a result, diagnostic catheters, which facilitate the diagnosis of CAD during this procedure, experienced increased unit sales translating into a market increase of 47% in Q1 2007 compared to Q1 2006.
About Interventional Cardiology Marketrack
Interventional Cardiology Marketrack™ gathers data from over 140 cath labs throughout the US on a monthly basis. Product categories covered include drug-eluting coronary stents, bare-metal coronary stents, PTCA balloons, guide wires, guiding catheters, diagnostic catheters, embolic protection devices, IVUS catheters, introducer sheaths, atherectomy devices, thrombectomy devices, inflation devices and vascular closure devices. MRG also gathers data from Europe, Japan, Asia Pacific, Latin America and the Middle East. Marketrack subscribers receive thousands of data points, including usage (units, average selling price, and revenue), procedure, competitor, and brand information.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
###
|
